Australian national health technology assessment: what roles has economics and transparency played in translating it into policy?

Health technology assessment is inherently multi-disciplinary, requiring technical and process competence. This presentation will focus on economics as an example of technical competence, and transparency as an example of process competence. There is no single preferred option, advantages and disadvantages of different options will be presented for discussion.

About Andrew

Andrew Mitchell recently retired from the Australian Government Department of Health and Aged Care following more than thirty years of involvement in health technology assessment. Trained as a pharmacist and with research experience in pharmacoepidemiology, he steered the development of several approaches to apply clinical and economic analyses systematically to inform resource allocation decisions in a publicly funded health care system. Following an early emphasis in considering whether and how medicines should be subsidised via the Pharmaceutical Benefits Scheme, he then became involved in developing the Australian Government’s arrangements for health technology assessment across other technologies, including investigative health technologies and codependent health technologies.